Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
04/1998
04/07/1998US5736391 HIV gp41 mutants
04/07/1998US5736388 Genetic engineering
04/07/1998US5736359 Vector containing dominant activator sequence and heterologous gene linked to promoter, for transfection of mammalian cells to obtain expression of desired gene
04/07/1998US5736338 Method of diagnosing Neoplastic disease by detecting increased expression of human MDM2 protein
04/07/1998US5736337 Inhibiting protein interactions
04/07/1998US5736294 Genetic engineering
04/07/1998US5736157 Parenterally administering a therapeutically effective amount of a lipid acceptor
04/02/1998WO1998013526A1 Three component chimeric antisense oligonucleotides
04/02/1998WO1998013510A1 Improved adenovirus vectors generated from helper viruses and helper-dependent vectors
04/02/1998WO1998013509A1 Novel morphogen-responsive signal transducer and methods of use thereof
04/02/1998WO1998013499A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
04/02/1998WO1998013496A1 Chaperone fragments
04/02/1998WO1998013493A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
04/02/1998WO1998013489A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation
04/02/1998WO1998013487A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection
04/02/1998WO1998013485A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection
04/02/1998WO1998013380A1 Snrnp sm proteins
04/02/1998WO1998013071A1 Gene therapy for inhibition of angiogenesis
04/02/1998WO1998013070A1 Non-invasive administration of adeno-associated viral vectors
04/02/1998WO1998013029A1 Oral delayed immediate release formulation and method of preparation therefor
04/02/1998WO1998013026A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
04/02/1998WO1998007878A3 Long-term expression of gene products by transforming muscle cells
04/02/1998CA2268945A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
04/02/1998CA2268265A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection
04/02/1998CA2267666A1 Novel morphogen-responsive signal transducer and methods of use thereof
04/02/1998CA2266855A1 Improved adenovirus vectors generated from helper viruses and helper-dependent vectors
04/02/1998CA2266619A1 Non-invasive administration of adeno-associated viral vectors
04/02/1998CA2266427A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation
04/02/1998CA2266423A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection
04/02/1998CA2266419A1 Gene therapy for inhibition of angiogenesis
04/02/1998CA2264544A1 Snrnp sm proteins
04/02/1998CA2213257A1 Oligopeptide derivatives
04/01/1998EP0832981A1 DNA sequences to target proteins to the mammary gland for efficient secretion
04/01/1998EP0832980A1 Recombinant therapies for infection and hyperproliferative disorders
04/01/1998EP0832977A2 Novel sugar kinase
04/01/1998EP0832975A2 Histidinol dehydrogenase from Staphylococcus aureus
04/01/1998EP0832973A2 GTP-binding protein
04/01/1998EP0832289A1 Novel gene-up regulated in regenerating liver
04/01/1998EP0832282A1 IMPROVED METHOD FOR OBTAINING FULL-LENGTH cDNA SEQUENCES
04/01/1998EP0832273A1 Synthetic mammalian chromosome and methods for construction
04/01/1998EP0832272A1 Cationic lipid:dna complexes for gene targeting
04/01/1998EP0832271A2 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
04/01/1998EP0832270A1 Cationic lipid:dna complexes for gene targeting
04/01/1998EP0832269A1 Nucleic acid transporters for delivery of nucleic acids into a cell
04/01/1998EP0832267A1 Adenovirus vectors for gene therapy
04/01/1998EP0832266A1 Oral delivery of adeno-associated viral vectors
04/01/1998EP0832265A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection
04/01/1998EP0832264A1 Plasmid for delivery of nucleic acids to cells and methods of use
04/01/1998EP0832260A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN
04/01/1998EP0832253A2 Nucleic acid respiratory syncytial virus vaccines
04/01/1998EP0832236A1 Methods for enhancement of protective immune responses
04/01/1998EP0832233A1 Human chemokine beta-13
04/01/1998EP0832231A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
04/01/1998EP0832227A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
04/01/1998EP0832222A2 Linc-53 from c. elegans and its uses in listing compounds involved in the control of cell behaviour and pharmaceutical compositions
04/01/1998EP0832217A1 Modified steroid hormones for gene therapy and methods for their use
04/01/1998EP0832216A1 Fibroblast growth factor 15
04/01/1998EP0832215A1 Fibroblast growth factor 11
04/01/1998EP0832213A1 TNF-$g(a) RIBOZYMES, TNF-$g(a) RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES
04/01/1998EP0832204A1 Treatment of insulin resistance
04/01/1998EP0832203A1 Use of neuro-derived fetal cell lines for transplantation therapy
04/01/1998EP0832202A1 Aav directed targeted integration
04/01/1998EP0832196A1 Immortalization and disimmortalization of cells
04/01/1998EP0832190A1 Essential oligonucleotides of vertebrate telomerase
04/01/1998EP0832128A2 Thrombin receptor homolog
04/01/1998EP0832126A1 G-protein receptor htnad29
04/01/1998EP0832125A1 Human g-protein receptor hgber32
04/01/1998EP0832112A1 Monocyte chemotactic protein-4
04/01/1998EP0832109A1 Fibroblast growth factor homologous factor-2 and methods of use
04/01/1998EP0831925A1 The regulation of systemic immune responses utilizing cytokines and antigens
04/01/1998EP0831924A1 Method of treatment for asthma
04/01/1998EP0831923A1 Separation of active complexes
04/01/1998EP0831922A2 Improved pharmaceutical compositions for gene therapy
04/01/1998EP0831921A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
04/01/1998EP0831919A1 Method for pharmaceutical delivery
04/01/1998EP0831903A1 Connective tissue growth factor
04/01/1998EP0831899A1 Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (rhdv)] compositions and uses
04/01/1998EP0831885A1 Methods and uses of connective tissue growth factor as an induction agent
04/01/1998EP0831879A1 Method for identifying or isolating a molecule and molecules identified thereby
04/01/1998EP0831875A1 Methods of inhibiting phagocytosis
04/01/1998EP0831874A1 Gene therapy for myocardial ischemia
04/01/1998EP0831866A1 Pineal gland specific gene-1
04/01/1998EP0831854A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
04/01/1998EP0831848A1 Method of treatment for lung diseases using antisense oligonucleotides
04/01/1998EP0831846A1 Capped synthetic rna, analogs, and aptamers
04/01/1998EP0831782A1 Methods and system for processing dispersible fine powders
04/01/1998EP0831771A2 Oral delivery of gene constructs
03/1998
03/31/1998US5734038 Purified polynucleotide sequence which codes for a diazepam binding inhibitor protein(or polypeptide) or an acyl-coenzyme a binding protein(or polypeptide)
03/31/1998US5733876 Method of inhibiting angiogenesis
03/31/1998US5733761 Gene therapy
03/31/1998US5733748 Isolated polynucleotide; cancer diagnosis
03/31/1998US5733727 Myocardial grafts and cellular compositions
03/31/1998US5733600 Method and apparatus for preparing sample cartridges for a particle acceleration device
03/31/1998US5733543 Genetic engineering; delaying acquired immune deficiency syndrome (aids) onset
03/26/1998WO1998012338A1 Improved retroviral vectors for gene therapy
03/26/1998WO1998012332A1 Compositions and methods for treating intracellular diseases
03/26/1998WO1998012328A2 Human bad polypeptides, encoding nucleic acids and methods of use
03/26/1998WO1998012327A2 Compositions and methods comprising bard1 and other brca1 binding proteins
03/26/1998WO1998012326A1 Hedgehog interacting proteins and uses related thereto
03/26/1998WO1998012324A1 Monocyte chemotactic protein 5 (mcp-5) molecules and uses therefor
1 ... 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 ... 870